Showing results (11-20 of 334) with videos related to
Sort By:
Pageof 34
Risk Management and Healthcare Policy|February 8, 2012
Perceptions of risk: understanding cardiovascular diseaseRuth Webster, Emma HeeleyPlos Medicine|March 30, 2016
Pragmatic Trials for Noncommunicable Diseases: Relieving ConstraintsAnushka Patel, Ruth WebsterHypertension Research : Official Journal of the Japanese Society of Hypertension|October 13, 2022
Reduced efficacy of blood pressure lowering drugs in the presence of diabetes mellitus-results from the TRIUMPH randomised controlled trialSonali R Gnanenthiran, Ruth Webster, Asita de Silva, et al.Therapeutic Advances in Drug Safety|February 2, 2018
Polypills for the secondary prevention of cardiovascular disease: effective in improving adherence but are they safe?Vanessa Selak, Ruth WebsterAmerican Heart Journal|January 21, 2014
TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocolAbdul Salam, Ruth Webster, Kavita Singh, et al.Clinical Therapeutics|September 17, 2016
More Versus Less Blood Pressure Lowering: An UpdateEmily R Atkins, Anthony RodgersJACC. Advances|June 24, 2025
Low-Dose Combinations With 3 or 4 Blood Pressure-Lowering Medications for the Treatment of HypertensionNelson Wang, Phidias Rueter, Abdul Salam, et al.Cardiovascular Therapeutics|August 18, 2015
The Effect of a Cardiovascular Polypill Strategy on Pill BurdenMichael Truelove, Anushka Patel, Severine Bompoint, et al.Bulletin of the World Health Organization|January 18, 2005
Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic reviewJennie Connor, Natasha Rafter, Anthony RodgersANZ Journal of Surgery|May 25, 2002
Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New ZealandNatalie Walker, Anthony Rodgers, Harley GrayPageof 34